Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
| Image |  |
|---|---|
| Description | scientific article published on 22 October 2014 |
| Author/s |
author: Lakshmi Nayak Andrew D Norden Debra C LaFrankie Sandra F Ruland Sarah C Gaffey Glenn J Lesser Jennifer A Rifenburg Julee R Pulverenti David A Reardon Mikael Rinne Benjamin Purow Eudocia Q Lee Manmeet S Ahluwalia Keith L Ligon Alona Muzikansky Katrina Smith Korfmacher Patrick Y Wen Christine McCluskey |
| Publication date | October 22, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |